The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...
Pharmacy advocate groups are teaming up with lawmakers to get new legislation passed to stop monopolistic behaviors from Pharmacy Benefit Managers.
CMS is expected to publish up to 15 drugs for the second cycle of the program by Feb. 1, and these are some of the drugs most ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
Can Walgreens Boots Alliance stock continue rising, or should investors use the stock's recent gain as an opportunity to exit ...
Tengfei Xu (Research Center for Clinical Pharmacy ... affected by drugs. Emerging techniques, such as single-cell metabolomics, artificial intelligence, and mass spectrometry imaging, are also ...
The generic drugs are procured from Indian drug makers that are certified by the WHO for following good manufacturing ...
The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
Gov. Kathy Hochul unveiled a range of health care proposals on Tuesday that focus on ramping up treatment for people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback